A strawberry-flavoured tablet for children living with HIV will be rolled out in African countries in 2021, the first generic pediatric version of a key anti-retroviral available even for babies, aid agencies announced on World AIDS Day on Tuesday. This, News24 reports, after Unitaid, a global health agency, and the Clinton Health Access Initiative reached a pricing agreement with generic drugmakers for the dispersible pediatric formulation of dolutegravir. The estimated cost for combination therapy will now be some $120 for a child’s annual treatment, against $480 currently, making it a “game-changer” for poorer countries, Unitaid said.